EPA Enriched Ethanolamine Plasmalogens Significantly Improve Cognition of Alzheimer’s Disease Mouse Model by Suppressing Β-Amyloid Generation

Hongxia Che,Miaomiao Zhou,Tiantian Zhang,Lingyu Zhang,Lin Ding,Teruyoshi Yanagita,Jie Xu,Changhu Xue,Yuming Wang

DOI: https://doi.org/10.1016/j.jff.2017.12.016

IF: 5.6

2018-01-01

Journal of Functional Foods

Abstract:EPA enriched ethanolamine plasmalogens (EPA-pPE) are important bioactive components and widely distributed in multifarious marine products. In the present study, Chinese hamster ovary cells stably transfected with APP751 and PS1 (CHO-APP/PS1 cells) and high-fat feeding SAMP8 mice were used to study the effects of EPA-pPE on Alzheimer’s disease (AD). The in vitro experiments showed that EPA-pPE exerted better effects than EPA-PE and Egg-PE in decreasing the intracellular and extracellular Aβ levels. EPA-pPE obviously improved learning and memory function of high-fat feeding SAMP8 mice by Morris maze test. Further mechanism research indicated that EPA-pPE could significantly improve cognition of Alzheimer’s disease by suppressing β-amyloid generation via reducing levels of APP and altering APP cleavage, thereby inhibiting oxidative stress, hyper-phosphorylated tau, neuro-inflammation and apoptosis. These results suggested that EPA-pPE might be applied as food supplements and/or functional ingredients to relieve neurodegenerative disease.